Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 64.5 | 74 | |
N2586 | PI103 | 0.1 | uM | 3 | HGF | 40.0 | 74 | ||||
0 | HGF | 18.0 | 69 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | HGF | 93.0 | 53 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 78.5 | 62 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 79.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 88.0 | 44 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 85.5 | 50 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 46.5 | 62 | |
RA2159 | EO1428 | 1.0 | uM | 3 | HGF | 33.5 | 40 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | HGF | 136.0 | 65 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 143.0 | 90 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 127.0 | 81 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 150.0 | 56 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 72.0 | 50 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | HGF | 105.5 | 68 | |
N2586 | EO1428 | 1.0 | uM | 3 | HGF | 61.0 | 70 | ||||
0 | HGF | 20.0 | 44 | ||||||||
RA2159 | 3 | HGF | 53.0 | 69 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | HGF | 45.0 | 53 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | HGF | 40.0 | 67 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | HGF | 42.0 | 46 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | HGF | 46.0 | 67 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | HGF | 46.0 | 57 | ||||
RA2159 | 3 | HGF | 47.0 | 65 |